Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
catherine.borg@ndm.ox.ac.uk

Catherine Borg

Clinical Research Nurse

Recent publications

nalysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma.

McDowell PJ. et al, (2025), The Journal of allergy and clinical immunology, 156, 911 - 922

irway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma

Howell I. et al, (2024), Journal of Allergy and Clinical Immunology, 154, 1146 - 1158

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma

Moran A. et al, (2020), Airway pharmacology and treatment, 2252 - 2252

Mechanisms of FeNO Non-Suppression in Severe Asthma: Analysis of Sputum Type 2 Cytokines and Chemokines

Couillard S. et al, (2020), EUROPEAN RESPIRATORY JOURNAL, 56

Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma

Hilvering B. et al, (2018), Mucosal Immunology, 11, 1408 - 1419

More publications